Literature DB >> 15257687

Pain and sensory complaints in multiple sclerosis.

A G Beiske1, E D Pedersen, B Czujko, K-M Myhr.   

Abstract

Pain is a frequent and disabling symptom among multiple sclerosis (MS) patients. The importance of this problem was investigated in a hospital based MS population. A total of 142 MS patients underwent neurological examination and a structured interview for registration of pain and sensory symptoms. One-hundred and five patients reported sensory and/or pain symptoms. Pain was reported by 93 patients and was most frequently located in the limbs and lumbar region. The presence of pain was independent of gender, age at onset and examination, disability, disease course and duration. The most frequently reported characteristics of the symptoms were paresthesia, neuralgia and deep muscular aching. About 40% of the patients reported that the symptoms had important influence on daily activities. Only one-third of the patients were treated for their pain. Pain is a frequent and disabling symptom, independent of demographic and clinical variables in MS patients. The low frequency of treatment for these symptoms indicates a need for improved attention to this problem.

Entities:  

Mesh:

Year:  2004        PMID: 15257687     DOI: 10.1111/j.1468-1331.2004.00815.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  31 in total

1.  Validation of the Comprehensive International Classification of Functioning, Disability, and Health Core Set for multiple sclerosis from the perspective of physicians.

Authors:  Stephanie Berno; Michaela Coenen; Andreas Leib; Alarcos Cieza; Jürg Kesselring
Journal:  J Neurol       Date:  2012-01-24       Impact factor: 4.849

2.  Systematic assessment and characterization of chronic pain in multiple sclerosis patients.

Authors:  Diana Ferraro; Domenico Plantone; Franca Morselli; Giulia Dallari; Anna M Simone; Francesca Vitetta; Patrizia Sola; Guido Primiano; Viviana Nociti; Matteo Pardini; Massimiliano Mirabella; Catello Vollono
Journal:  Neurol Sci       Date:  2017-12-09       Impact factor: 3.307

3.  The impact of pain and other symptoms on quality of life in women with relapsing-remitting multiple sclerosis.

Authors:  Pamela K Newland; Robert T Naismith; Margaret Ullione
Journal:  J Neurosci Nurs       Date:  2009-12       Impact factor: 1.230

Review 4.  Multiple sclerosis-related central pain disorders.

Authors:  Turo J Nurmikko; Sameer Gupta; Kate Maclver
Journal:  Curr Pain Headache Rep       Date:  2010-06

5.  A comparison of self-hypnosis versus progressive muscle relaxation in patients with multiple sclerosis and chronic pain.

Authors:  Mark P Jensen; Joseph Barber; Joan M Romano; Ivan R Molton; Katherine A Raichle; Travis L Osborne; Joyce M Engel; Brenda L Stoelb; George H Kraft; David R Patterson
Journal:  Int J Clin Exp Hypn       Date:  2009-04

Review 6.  Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-analysis.

Authors:  Shahnaz Shahrbanian; Mohammad Auais; Pierre Duquette; Katie Andersen; Katie Anderson; Nancy E Mayo
Journal:  Pain Res Manag       Date:  2013 Sep-Oct       Impact factor: 3.037

Review 7.  Pain and multiple sclerosis: pathophysiology and treatment.

Authors:  Claudio Solaro; Erika Trabucco; Michele Messmer Uccelli
Journal:  Curr Neurol Neurosci Rep       Date:  2013-01       Impact factor: 5.081

8.  Longitudinal 7-year follow-up of chronic pain in persons with multiple sclerosis in the community.

Authors:  Fary Khan; Bhasker Amatya; Jürg Kesselring
Journal:  J Neurol       Date:  2013-04-25       Impact factor: 4.849

Review 9.  Current management of pain associated with multiple sclerosis.

Authors:  Walter Pöllmann; Wolfgang Feneberg
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

10.  Prevalence and impact of pain in multiple sclerosis: physical and psychologic contributors.

Authors:  Adam T Hirsh; Aaron P Turner; Dawn M Ehde; Jodie K Haselkorn
Journal:  Arch Phys Med Rehabil       Date:  2009-04       Impact factor: 3.966

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.